← Open Payments lookup

MILOS TOMIC: Open Payments

NPI 1427532993 · MANCHESTER, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,710 in 71 payments from 14 companies in 2025. Trend: 2023 $2,450 · 2024 $2,036 · 2025 $1,710

Food & beverage: $1,710
CompanyPaymentsAmount
GlaxoSmithKline, LLC.40$580
AstraZeneca Pharmaceuticals LP12$480
Actelion Pharmaceuticals US, Inc.2$189
Regeneron Healthcare Solutions, Inc.3$116
GENZYME CORPORATION2$63
Merck Sharp & Dohme LLC2$59
Verona Pharma, Inc.2$54
Mallinckrodt Hospital Products Inc.2$41
Takeda Pharmaceuticals U.S.A., Inc.1$30
Baxter Healthcare1$23

Products named: NUCALA, AIRSUPRA, TEZSPIRE, UPTRAVI, DUPIXENT, TRELEGY ELLIPTA, WINREVAIR, Ohtuvayre.

Industry payments across CT — which companies pay providers there.